New carriers and adjuvants in the development of vaccines
- 1 January 1992
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 4 (4) , 454-459
- https://doi.org/10.1016/s0952-7915(06)80038-5
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Non-inflammatory peptide fragments of IL1 as safe new-generation adjuvantsResearch in Immunology, 1992
- Exact prediction of a natural T cell epitopeEuropean Journal of Immunology, 1991
- Adverse reactions after injection of adsorbed diphtheria—pertussis—tetanus (DPT) vaccine are not due only to pertussis organisms or pertussis components in the vaccineVaccine, 1991
- Targeting and controlled release of antigens for the effective induction of secretory antibody responsesCurrent Opinion in Immunology, 1991
- Model using a peptide with carrier function for vaccination against different pathogensVaccine, 1991
- Adjuvant Effect of Human Growth Hormone with an Inactivated Flavivirus VaccineThe Journal of Infectious Diseases, 1991
- Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC moleculesNature, 1991
- Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cellsEuropean Journal of Immunology, 1989
- Different T helper cell subsets elicited in mice utilizing two different adjuvant vehicles: The role of endogenous interleukin 1 in proliferative responsesCellular Immunology, 1989
- Cellular Immune Responses in the Murine Lung to Local Immunization with Influenza A Virus Glycoproteins in Micelles and Immunostimulatory Complexes (Iscoms)Scandinavian Journal of Immunology, 1988